OLIVIA QUIDO BLEMISH ERASER .02 g/g
Hydroquinone · CREAM · O Skin Care LLC
No Recall History
Plain English
OLIVIA QUIDO BLEMISH ERASER is a cream containing hydroquinone at .02 g/g, taken topical. Manufactured by O Skin Care LLC.
Key Facts
- Brand Name
- OLIVIA QUIDO BLEMISH ERASER
- Generic Name
- Hydroquinone
- NDC Code (Product)
71421-801- Manufacturer
- O Skin Care LLC
- Strength
- .02 g/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Drug Class
- Melanin Synthesis Inhibitor [EPC]
- Marketing Start
- 05/04/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is OLIVIA QUIDO BLEMISH ERASER used for?
OLIVIA QUIDO BLEMISH ERASER contains Hydroquinone. It is a cream taken topical. Consult your doctor for specific uses.
Is OLIVIA QUIDO BLEMISH ERASER a controlled substance?
OLIVIA QUIDO BLEMISH ERASER is not classified as a controlled substance by the DEA.
What is the generic name for OLIVIA QUIDO BLEMISH ERASER?
The generic name for OLIVIA QUIDO BLEMISH ERASER is Hydroquinone. There are 12 other brand versions of Hydroquinone.
What is the NDC code for OLIVIA QUIDO BLEMISH ERASER .02 g/g?
The NDC (National Drug Code) for OLIVIA QUIDO BLEMISH ERASER .02 g/g is 71421-801, listed by O Skin Care LLC.
Other Hydroquinone Brands
See all →- Hydroquinone 4%40 mg/g75834-137
- Hydroquinone 4%40 mg/g50405-800
- OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C40 mg/mL62032-122
- Obagi Nu-Derm System Normal-Dry Skin Transformation Kit62032-911
- HYDROQUINONE 4%40 mg/g71399-0400
- ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin C.04 mg/mL42851-035
- Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E40 mg/g62032-105
- NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL62032-532
- Obagi-C C-Rx System Normal-Dry Skin Intervention62032-916
- Obagi Nu-Derm System Normal-Oily Skin Transformation62032-919
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)